SMMT - Summit Therapeutics plc

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5215.37M
Enterprise Value 3193.14M
Trailing P/E N/A
Forward P/E 1-6.75
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)6.00
Price/Book (mrq)13.94
Enterprise Value/Revenue 35.39
Enterprise Value/EBITDA 6-9.18

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Jan 31, 2018
Most Recent Quarter (mrq)Jan 31, 2018

Profitability

Profit Margin -28.00%
Operating Margin (ttm)-59.32%

Management Effectiveness

Return on Assets (ttm)-20.62%
Return on Equity (ttm)-223.47%

Income Statement

Revenue (ttm)35.87M
Revenue Per Share (ttm)2.74
Quarterly Revenue Growth (yoy)76.90%
Gross Profit (ttm)40.02M
EBITDA -21.04M
Net Income Avi to Common (ttm)-10.04M
Diluted EPS (ttm)-0.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)28.32M
Total Cash Per Share (mrq)1.73
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.89
Book Value Per Share (mrq)0.94

Cash Flow Statement

Operating Cash Flow (ttm)-20.69M
Levered Free Cash Flow (ttm)-14.83M

Trading Information

Stock Price History

Beta 0.83
52-Week Change 318.04%
S&P500 52-Week Change 313.05%
52 Week High 316.86
52 Week Low 38.80
50-Day Moving Average 313.68
200-Day Moving Average 312.41

Share Statistics

Avg Vol (3 month) 338.89k
Avg Vol (10 day) 334.72k
Shares Outstanding 561.84M
Float 11.5M
% Held by Insiders 11.42%
% Held by Institutions 124.54%
Shares Short 33.28k
Short Ratio 30.06
Short % of Float 30.00%
Shares Short (prior month) 39.6k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A